Allergan Entertaining Offer From Actavis Over $200 Per ShareMark Melin
Bloomberg is reporting that Actavis plc (NYSE:ACT) is in talks to acquire Allergan, Inc. (NYSE:AGN) for a price north of $200 per share. Allergan is said to want over $210 per share while Actavis is said to currently be willing to pay just over . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.